HEAAL: the final chapter in the story of angiotensin receptor blockers in heart failure-lessons learnt from a decade of trials

被引:6
作者
McMurray, John J. V. [1 ]
Swedberg, Karl [2 ]
机构
[1] Univ Glasgow, BHF Glasgow Cardiovasc Res Ctr, Glasgow G12 8TA, Lanark, Scotland
[2] Univ Gothenburg, Dept Emergency & Cardiovasc Med, Sahlgrenska Acad, SE-41685 Gothenburg, Sweden
关键词
CONVERTING-ENZYME-INHIBITORS; VENTRICULAR SYSTOLIC FUNCTION; RANDOMIZED-TRIAL; MYOCARDIAL-INFARCTION; EJECTION FRACTION; HIGH-RISK; MORTALITY; CANDESARTAN; MORBIDITY; LOSARTAN;
D O I
10.1093/eurjhf/hfp197
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
引用
收藏
页码:99 / 103
页数:5
相关论文
共 23 条
[1]
Are angiotensin II receptor blockers more efficacious than placebo in heart failure? Implications of ELITE-2 [J].
Berry, C ;
Norrie, J ;
McMurray, JJV .
AMERICAN JOURNAL OF CARDIOLOGY, 2001, 87 (05) :606-607
[2]
Determining the most appropriate components for a composite clinical trial outcome [J].
Bethel, M. Angelyn ;
Holman, Rury ;
Haffner, Steven M. ;
Califf, Robert M. ;
Huntsman-Labed, Alice ;
Hua, Tsushung A. ;
McMurray, John .
AMERICAN HEART JOURNAL, 2008, 156 (04) :633-640
[3]
Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy [J].
Brenner, BM ;
Cooper, ME ;
de Zeeuw, D ;
Keane, WF ;
Mitch, WE ;
Parving, HH ;
Remuzzi, G ;
Snapinn, SM ;
Zhang, ZX ;
Shahinfar, S .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (12) :861-869
[4]
A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure [J].
Cohn, JN ;
Tognoni, G .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (23) :1667-1675
[5]
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE):: a randomised trial against atenolol [J].
Dahlöf, B ;
Devereux, RB ;
Kjeldsen, SE ;
Julius, S ;
Beevers, G ;
de Faire, U ;
Fyhrquist, F ;
Ibsen, H ;
Kristiansson, K ;
Lederballe-Pedersen, O ;
Lindholm, LH ;
Nieminen, MS ;
Omvik, P ;
Oparil, S ;
Wedel, H .
LANCET, 2002, 359 (9311) :995-1003
[6]
Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAL randomised trial [J].
Dickstein, K ;
Kjekshus, J .
LANCET, 2002, 360 (9335) :752-760
[7]
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008 The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM) [J].
Dickstein, Kenneth ;
Cohen-Solal, Alain ;
Filippatos, Gerasimos ;
McMurray, John J. V. ;
Ponikowski, Piotr ;
Poole-Wilson, Philip Alexander ;
Stromberg, Anna ;
van Veldhuisen, Dirk J. ;
Atar, Dan ;
Hoes, Amo W. ;
Keren, Andre ;
Mebazaa, Alexandre ;
Nieminen, Markku ;
Priori, Silvia Gluliana ;
Swedberg, Karl .
EUROPEAN JOURNAL OF HEART FAILURE, 2008, 10 (10) :933-989
[8]
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors:: the CHARM-Alternative trial [J].
Granger, CB ;
McMurray, JJV ;
Yusuf, S ;
Held, P ;
Michelson, EL ;
Olofsson, B ;
Östergren, J ;
Pfeffer, MA ;
Swedberg, K .
LANCET, 2003, 362 (9386) :772-776
[9]
Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trial [J].
Konstam, Marvin A. ;
Neaton, James D. ;
Dickstein, Kenneth ;
Drexler, Helmut ;
Komajda, Michel ;
Martinez, Felipe A. ;
Riegger, Gunter A. J. ;
Malbecq, William ;
Smith, Ronald D. ;
Guptha, Soneil ;
Poole-Wilson, Philip A. .
LANCET, 2009, 374 (9704) :1840-1848
[10]
Intensive lipid lowering with atorvastatin in patients with stable coronary disease [J].
LaRosa, JC ;
Grundy, SM ;
Waters, DD ;
Shear, C ;
Barter, P ;
Fruchart, J ;
Gotto, AM ;
Greten, H ;
Kastelein, JJP ;
Shepherd, J ;
Wenger, NK .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (14) :1425-1435